【新股IPO】科濟藥業2171傳以上限32.8元定價 – 香港經濟日報 – 即時新聞頻道 – iMoney智富 – 股樓投資 2021-06-10T11:44:00-04:00June 10th, 2021| share this article! 內地生物製藥公司科濟藥業(新上市編號:02171)剛截飛,消息指,該股計劃以招股上限32.8元定價,其招股範圍介乎29.6至32.8元,預期集資約31億元。科濟藥業是次發行9,474.7萬股,當中10 Read More share this article! Related Posts India’s Vodafone Idea in talks to avail $1.8b loans over two years May 2nd, 2024 AI-SaaS company AiDash closes Series C round at $58.5m led by Lightsmith Group May 2nd, 2024 In Asia, US dollar’s growing strength fuels concern over currency stability May 2nd, 2024 Morgan Stanley, India Life Sciences Fund inject $120m into India’s Maiva Pharma May 2nd, 2024